| Emily Choi Decroos, MD | |
|
1 Medical Center Blvd, Acp # 533, Chester, PA 19013-3902 | |
| (610) 874-1184 | |
| (610) 872-4258 |
| Full Name | Emily Choi Decroos |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 18 Years |
| Location | 1 Medical Center Blvd, Chester, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114041902 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Healthcare System, Inc | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Health Partners Foundation, Inc | 8022919570 | 303 |
News Archive
Side effects from drugs working in non-target locations within the body can cause debilitating symptoms, often resulting in patients stopping their course of treatment early.
Sermonix Pharmaceuticals LLC, a specialty pharmaceutical company focused on the development and commercialization of emerging late-stage women's health products, today announced it received top honors for its research on investigational drug lasofoxifene at the 26th annual North American Menopause Society (NAMS) meeting in Las Vegas last week.
Takeda Pharmaceutical Company Limited ("Takeda") and Pfizer Inc. ("Pfizer") announced that they have entered into an agreement under which Pfizer in China will co-promote Takeda's Actos® (pioglitazone HCl) with Tianjin Takeda Pharmaceuticals in China.
The use of isokinetic dynamometers with older adults extends far beyond orthopedics, but the reliability and responsiveness of isokinetic measures in conditions like COPD and stroke are still being evaluated, report experts in Isokinetics and Exercise Science.
Oregon Health & Science University Knight Cancer Institute researchers are closer to understanding why certain chronic myeloid leukemia mutations are not stopped by the revolutionary targeted cancer pill, Gleevec, or similar therapies in that drug family.
› Verified 4 days ago
| Entity Name | University Health System, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790738763 PECOS PAC ID: 5294646378 Enrollment ID: O20031111000809 |
News Archive
Side effects from drugs working in non-target locations within the body can cause debilitating symptoms, often resulting in patients stopping their course of treatment early.
Sermonix Pharmaceuticals LLC, a specialty pharmaceutical company focused on the development and commercialization of emerging late-stage women's health products, today announced it received top honors for its research on investigational drug lasofoxifene at the 26th annual North American Menopause Society (NAMS) meeting in Las Vegas last week.
Takeda Pharmaceutical Company Limited ("Takeda") and Pfizer Inc. ("Pfizer") announced that they have entered into an agreement under which Pfizer in China will co-promote Takeda's Actos® (pioglitazone HCl) with Tianjin Takeda Pharmaceuticals in China.
The use of isokinetic dynamometers with older adults extends far beyond orthopedics, but the reliability and responsiveness of isokinetic measures in conditions like COPD and stroke are still being evaluated, report experts in Isokinetics and Exercise Science.
Oregon Health & Science University Knight Cancer Institute researchers are closer to understanding why certain chronic myeloid leukemia mutations are not stopped by the revolutionary targeted cancer pill, Gleevec, or similar therapies in that drug family.
› Verified 4 days ago
| Entity Name | Memorial Health Partners Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922053545 PECOS PAC ID: 8022919570 Enrollment ID: O20040116000823 |
News Archive
Side effects from drugs working in non-target locations within the body can cause debilitating symptoms, often resulting in patients stopping their course of treatment early.
Sermonix Pharmaceuticals LLC, a specialty pharmaceutical company focused on the development and commercialization of emerging late-stage women's health products, today announced it received top honors for its research on investigational drug lasofoxifene at the 26th annual North American Menopause Society (NAMS) meeting in Las Vegas last week.
Takeda Pharmaceutical Company Limited ("Takeda") and Pfizer Inc. ("Pfizer") announced that they have entered into an agreement under which Pfizer in China will co-promote Takeda's Actos® (pioglitazone HCl) with Tianjin Takeda Pharmaceuticals in China.
The use of isokinetic dynamometers with older adults extends far beyond orthopedics, but the reliability and responsiveness of isokinetic measures in conditions like COPD and stroke are still being evaluated, report experts in Isokinetics and Exercise Science.
Oregon Health & Science University Knight Cancer Institute researchers are closer to understanding why certain chronic myeloid leukemia mutations are not stopped by the revolutionary targeted cancer pill, Gleevec, or similar therapies in that drug family.
› Verified 4 days ago
| Entity Name | Chattanooga Hamilton County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154751931 PECOS PAC ID: 0547179731 Enrollment ID: O20040302001086 |
News Archive
Side effects from drugs working in non-target locations within the body can cause debilitating symptoms, often resulting in patients stopping their course of treatment early.
Sermonix Pharmaceuticals LLC, a specialty pharmaceutical company focused on the development and commercialization of emerging late-stage women's health products, today announced it received top honors for its research on investigational drug lasofoxifene at the 26th annual North American Menopause Society (NAMS) meeting in Las Vegas last week.
Takeda Pharmaceutical Company Limited ("Takeda") and Pfizer Inc. ("Pfizer") announced that they have entered into an agreement under which Pfizer in China will co-promote Takeda's Actos® (pioglitazone HCl) with Tianjin Takeda Pharmaceuticals in China.
The use of isokinetic dynamometers with older adults extends far beyond orthopedics, but the reliability and responsiveness of isokinetic measures in conditions like COPD and stroke are still being evaluated, report experts in Isokinetics and Exercise Science.
Oregon Health & Science University Knight Cancer Institute researchers are closer to understanding why certain chronic myeloid leukemia mutations are not stopped by the revolutionary targeted cancer pill, Gleevec, or similar therapies in that drug family.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Choi Decroos, MD 7477 Commons Blvd., Apt. 731, Chattanooga, TN 37421 Ph: (919) 451-5685 | Emily Choi Decroos, MD 1 Medical Center Blvd, Acp # 533, Chester, PA 19013-3902 Ph: (610) 874-1184 |
News Archive
Side effects from drugs working in non-target locations within the body can cause debilitating symptoms, often resulting in patients stopping their course of treatment early.
Sermonix Pharmaceuticals LLC, a specialty pharmaceutical company focused on the development and commercialization of emerging late-stage women's health products, today announced it received top honors for its research on investigational drug lasofoxifene at the 26th annual North American Menopause Society (NAMS) meeting in Las Vegas last week.
Takeda Pharmaceutical Company Limited ("Takeda") and Pfizer Inc. ("Pfizer") announced that they have entered into an agreement under which Pfizer in China will co-promote Takeda's Actos® (pioglitazone HCl) with Tianjin Takeda Pharmaceuticals in China.
The use of isokinetic dynamometers with older adults extends far beyond orthopedics, but the reliability and responsiveness of isokinetic measures in conditions like COPD and stroke are still being evaluated, report experts in Isokinetics and Exercise Science.
Oregon Health & Science University Knight Cancer Institute researchers are closer to understanding why certain chronic myeloid leukemia mutations are not stopped by the revolutionary targeted cancer pill, Gleevec, or similar therapies in that drug family.
› Verified 4 days ago
Dr. Roger Louis Cambor, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2001 Providence Ave, Chester, PA 19013 Phone: 610-876-9000 Fax: 484-490-0116 | |
Dr. Khin Khin, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2600 W 9th St, Chester, PA 19013 Phone: 610-497-7636 Fax: 610-497-7711 | |
Dr. Ellen Elizabeth Bartolini, PSYD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1728 Walnut St, Chester, PA 19013 Phone: 610-499-1204 | |
Nicholas Alexander Beam, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Blvd Ste 231, Chester, PA 19013 Phone: 844-464-6387 | |
Dr. Abdulbari Khalid Farooqi, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Medical Center Blvd, Chester, PA 19013 Phone: 610-874-5257 Fax: 610-874-7241 | |
Dr. Deepak S Mahajan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Blvd, Chester, PA 19013 Phone: 610-874-5257 Fax: 610-874-7241 |